News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
196 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (7)
2 (15)
3 (243)
4 (292)
5 (235)
6 (83)
7 (4)
8 (20)
9 (229)
10 (249)
11 (163)
12 (210)
13 (72)
14 (2)
15 (29)
16 (196)
17 (228)
18 (224)
19 (189)
20 (95)
21 (7)
22 (4)
23 (193)
24 (210)
25 (262)
26 (241)
27 (78)
28 (20)
29 (55)
30 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Pharm Country
Multiple Myeloma Research Foundation Launches Third “Road to Victories” Epic Cycling Event from Vermont to Quebec
Team of 30, Including 8 Myeloma Patients, to Ride 10,000 Miles; More than $1.5 Million Raised to Accelerate Cures for Myeloma Patients
September 16, 2019
·
5 min read
The European Commission Horizon 2020 Program Backs Filterlex’s Embolic Protection Device - CAPTIS
Filterlex Medical, an innovative medical device startup in the cardiovascular field, today announced that the company has been selected for the Phase 2 Horizon 2020 SME Instrument program.
September 16, 2019
·
3 min read
BioCapital
Empowering Women at Midlife: New National Menopause Foundation Launches During National Menopause Month
In the United States, approximately 1.3 million women are expected to reach menopause every year.
September 16, 2019
·
2 min read
Business
Weill Cornell Medicine Eliminates Medical Education Debt for All Qualifying Students
A transformative new scholarship program established by Weill Cornell Medicine will eliminate medical education debt for all students who qualify for financial aid, the institution announced today.
September 16, 2019
·
9 min read
Job Trends
SwRI Offers Introductory Microencapsulation Workshop
Southwest Research Institute is offering an “Introduction to Microencapsulation Workshop” October 7-8 at its headquarters in San Antonio.
September 16, 2019
·
1 min read
Pharm Country
What Every College Girl Should Know About Sexual Health
Maria Sophocles, MD, OBGYN offers advice to maintain vaginal health, avoid issues down there, and stay safe when sexually active
September 16, 2019
·
3 min read
BioCapital
Dr. Gregory Jantz Launches Campaign to Battle Suicide Epidemic
Latest Groundbreaking Book Healing Depression for Life Has Practical Steps That Can Help
September 16, 2019
·
3 min read
Pharm Country
Exeltis USA, Inc. Announces the Launch of Slynd™(drospirenone) tablets, 4 mg, the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24-hour missed pill window and 24/4 Dosing Regimen
Exeltis USA, Inc. a division of Insud Pharma (headquartered in Madrid, Spain) today announced the commercial launch of its oral contraceptive tablet Slynd™ (drospirenone) tablets, 4 mg in the US market.
September 16, 2019
·
3 min read
Drug Development
VALBIOTIS Presents Positive Results From a Study on TOTUM-63, Active Substance of VALEDIA®, Conducted by the CarMeN Laboratory in Lyon, at the Annual Meeting of the European Association for the Study of Diabetes (EASD)
VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / PEA/SME eligible), a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, today announced the presentation of a preclinical study conducted by the CarMeN laboratory on the active substance TOTUM-63, at the 55th Annual Meeting of the European Association for the Study of Diabetes being held September 16-20, 2019
September 16, 2019
·
6 min read
Job Trends
American Association of Nurse Practitioners® Opens New National Headquarters Amid Sustained Growth, Renews Mission for Full Practice Authority
The American Association of Nurse Practitioners® (AANP) unveiled its newly constructed national headquarters in Austin, Texas on September 13, 2019.
September 16, 2019
·
2 min read
Previous
18 of 20
Next